Inhibiting tau-induced elevated nSMase2 activity and ceramides is therapeutic in an Alzheimer’s disease mouse model

Inhibiting tau-induced elevated nSMase2 activity and ceramides is therapeutic in an Alzheimer’s disease mouse model

Abstract Background Cognitive decline in Alzheimer’s disease (AD) is associated with hyperphosphorylated tau (pTau) propagation between neurons along synaptically connected networks, in part via extracellular vesicles (EVs). EV biogenesis is triggered by ceramide enrichment at the plasma membrane fr...

Full description

Bibliographic Details
Main Authors: Carolyn Tallon, Benjamin J. Bell, Medhinee M. Malvankar, Pragney Deme, Carlos Nogueras-Ortiz, Erden Eren, Ajit G. Thomas, Kristen R. Hollinger, Arindom Pal, Maja Mustapic, Meixiang Huang, Kaleem Coleman, Tawnjerae R. Joe, Rana Rais, Norman J. Haughey, Dimitrios Kapogiannis, Barbara S. Slusher
Format: Article
Language:English
Published: BMC 2023-12-01
Series:Translational Neurodegeneration
Subjects:
Alzheimer’s disease
Extracellular vesicles
Neutral sphingomyelinase 2
Tau
Ceramide
Online Access:https://doi.org/10.1186/s40035-023-00383-9

Internet

https://doi.org/10.1186/s40035-023-00383-9

Similar Items